Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengchun Wu

Showing results (11-20 of 153) with videos related to

Pageof 16
Sort By:
BMC Psychiatry|May 12, 2026
Temporal dynamic brain-heart interaction alterations associated with suicidal ideation in major depressive disorderZhaobo Li, Yuanyuan Huang, Jing Zhou, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 22, 2025
Low-dose paliperidone combined with sertraline for first-episode and medication-naïve patients with schizophrenia: an open-label, randomized trialHui Lin, Xiaoni Guan, Xiaoe Lang, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 4, 2026
Correction: Low-dose paliperidone combined with sertraline for first-episode and medication-naïve patients with schizophrenia: an open-label, randomized trialZhonghui Lin, Xiaoni Guan, Xiaoe Lang, et al.
Schizophrenia (Heidelberg, Germany)|January 15, 2024
Author Correction: A pilot study to examine the association between COX-2 rs5275 polymorphism and the response to repetitive transcranial stimulation in schizophreniaPingping Wang, Xiaoni Guan, Xiuru Su, et al.
BMC Psychiatry|October 22, 2025
Moderating role of familial relationships in the efficacy of rTMS intervention on cognitive function in patients with schizophreniaCheng Zhu, Jing Yao, Hengyong Guan, et al.
Current Neuropharmacology|October 20, 2023
Smoking, Symptoms Improvement, and Total Antioxidant Capacity in Patients with Drug-naive First-episode Schizophrenia: A Prospective Cohort StudyZhiyong Gao, Meihong Xiu, Jiahong Liu, et al.
Antioxidants (Basel, Switzerland)|April 23, 2022
Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone MonotherapyKeqiang Wang, Meihong Xiu, Xiuru Su, et al.
Frontiers in Neuroscience|January 28, 2022
Discriminative Analysis of Schizophrenia Patients Using Topological Properties of Structural and Functional Brain Networks: A Multimodal Magnetic Resonance Imaging StudyJing Wang, Pengfei Ke, Jinyu Zang, et al.
Journal of Affective Disorders|April 23, 2019
Altered whole brain functional connectivity pattern homogeneity in medication-free major depressive disorderLijie Wang, Lin Yu, Fengchun Wu, et al.
Schizophrenia (Heidelberg, Germany)|March 23, 2023
Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidoneZhiyong Gao, Meihong Xiu, Jiahong Liu, et al.
Pageof 16

Showing results (11-20 of 153) with videos related to

Sort By:
Pageof 16
BMC Psychiatry|May 12, 2026
Temporal dynamic brain-heart interaction alterations associated with suicidal ideation in major depressive disorderZhaobo Li, Yuanyuan Huang, Jing Zhou, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 22, 2025
Low-dose paliperidone combined with sertraline for first-episode and medication-naïve patients with schizophrenia: an open-label, randomized trialHui Lin, Xiaoni Guan, Xiaoe Lang, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 4, 2026
Correction: Low-dose paliperidone combined with sertraline for first-episode and medication-naïve patients with schizophrenia: an open-label, randomized trialZhonghui Lin, Xiaoni Guan, Xiaoe Lang, et al.
Schizophrenia (Heidelberg, Germany)|January 15, 2024
Author Correction: A pilot study to examine the association between COX-2 rs5275 polymorphism and the response to repetitive transcranial stimulation in schizophreniaPingping Wang, Xiaoni Guan, Xiuru Su, et al.
BMC Psychiatry|October 22, 2025
Moderating role of familial relationships in the efficacy of rTMS intervention on cognitive function in patients with schizophreniaCheng Zhu, Jing Yao, Hengyong Guan, et al.
Current Neuropharmacology|October 20, 2023
Smoking, Symptoms Improvement, and Total Antioxidant Capacity in Patients with Drug-naive First-episode Schizophrenia: A Prospective Cohort StudyZhiyong Gao, Meihong Xiu, Jiahong Liu, et al.
Antioxidants (Basel, Switzerland)|April 23, 2022
Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone MonotherapyKeqiang Wang, Meihong Xiu, Xiuru Su, et al.
Frontiers in Neuroscience|January 28, 2022
Discriminative Analysis of Schizophrenia Patients Using Topological Properties of Structural and Functional Brain Networks: A Multimodal Magnetic Resonance Imaging StudyJing Wang, Pengfei Ke, Jinyu Zang, et al.
Journal of Affective Disorders|April 23, 2019
Altered whole brain functional connectivity pattern homogeneity in medication-free major depressive disorderLijie Wang, Lin Yu, Fengchun Wu, et al.
Schizophrenia (Heidelberg, Germany)|March 23, 2023
Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidoneZhiyong Gao, Meihong Xiu, Jiahong Liu, et al.
Pageof 16